David MacLeod joined Blue Matter in 2026, bringing over 25 years of experience in market access and commercial leadership across pharma and consulting. He has diverse experience spanning market access, patient services, trade and distribution, reimbursement, and commercialization. David previously held roles at Amylyx, Intercept, EMD Serono, and Genzyme.

David holds a B.S. in Criminal Justice from Westfield State University.